Cargando…

A Narrative Review of Implementing Precision Oncology in Metastatic Castration-Resistant Prostate Cancer in Emerging Countries

The therapeutic landscape of metastatic castration-resistant prostate cancer (mCRPC) has evolved considerably with the introduction of newer agents, such as poly-ADP ribose polymerase (PARP) inhibitors targeting DNA damage repair mutations. Combining and sequencing novel and existing therapies appro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bazarbashi, Shouki, Su, Wen-Pin, Wong, Siew W., Singarachari, Ramanujam A., Rawal, Sudhir, Volkova, Maria I., Bastos, Diogo A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593077/ https://www.ncbi.nlm.nih.gov/pubmed/34236692 http://dx.doi.org/10.1007/s40487-021-00160-6

Ejemplares similares

Management of metastatic castration-resistant prostate cancer in Middle East African countries: Challenges and strategic recommendations
por: Bazarbashi, Shouki, et al.
Publicado: (2022)

Saudi Oncology Society clinical management guidelines development
por: Bazarbashi, Shouki N.
Publicado: (2014)

Elicitation of Health Utilities in Oncology in the Kingdom of Saudi Arabia
por: Iskedjian, Michael, et al.
Publicado: (2020)

Why local guidelines?
por: Bazarbashi, Shouki
Publicado: (2011)

Current challenges in the implementation of precision oncology for the management of metastatic colorectal cancer
por: Kim, Sun Young, et al.
Publicado: (2020)

Implementation of Precision Oncology for Patients with Metastatic Breast Cancer in an Interdisciplinary MTB Setting
por: Sultova, Elena, et al.
Publicado: (2021)

Global Implementation of Precision Oncology
por: Yam, Clinton, et al.
Publicado: (2021)

Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer
por: Bazarbashi, Shouki, et al.
Publicado: (2015)

Darolutamide For Castration-Resistant Prostate Cancer
por: Bastos, Diogo A, et al.
Publicado: (2019)

The Significance of Sidedness in Patients with Metastatic Colorectal Cancer Treated with Triplet First-Line Chemotherapy
por: Bazarbashi, Shouki, et al.
Publicado: (2019)

Efficacy and Prognostic Factors of Sunitinib as First-Line Therapy for Patients With Metastatic Renal Cell Carcinoma in an Arab Population
por: Badran, Ahmed, et al.
Publicado: (2020)

Efficacy and Safety of Docetaxel in Elderly Patients With Metastatic Castration-Resistant Prostate Cancer
por: Maia, Manuel Caitano, et al.
Publicado: (2017)

Chronological improvement in precision oncology implementation in Japan
por: Sunami, Kuniko, et al.
Publicado: (2022)

Outcomes and Prognostic Factors of Metastatic Gastric Cancer: A Single-Center Experience
por: Aseafan, Mohamed, et al.
Publicado: (2022)

Cancer Incidence in Saudi Arabia: 2012 Data from the Saudi Cancer Registry
por: Bazarbashi, Shouki, et al.
Publicado: (2017)

Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancer
por: Elshenawy, Mahmoud A., et al.
Publicado: (2020)

Finding the optimal treatment sequence in metastatic castration-resistant prostate cancer—a narrative review
por: Maurice Dror, Corinne, et al.
Publicado: (2021)

Methodological Approaches to Cost-Effectiveness Analysis in Saudi Arabia: What Can We Learn? A Systematic Review
por: Maraiki, Fatma, et al.
Publicado: (2022)

Consensus for Treatment of Metastatic Castration-Sensitive Prostate Cancer: Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC)
por: Maluf, Fernando Cotait, et al.
Publicado: (2021)

Efficacy of Regorafenib in Metastatic Colorectal Cancer: A Multi-institutional Retrospective Study
por: Aljubran, Ali, et al.
Publicado: (2019)

Saudi oncology society and Saudi urology association combined clinical management guidelines for urothelial urinary bladder cancer
por: Al-mansour, Mubarak, et al.
Publicado: (2014)

Current and upcoming radionuclide therapies in the direction of precision oncology: A narrative review
por: Shah, Hina J., et al.
Publicado: (2023)

Narrative review: prostate-specific membrane antigen-radioligand therapy in metastatic castration-resistant prostate cancer
por: Lunger, Lukas, et al.
Publicado: (2021)

Optimizing the treatment of metastatic castration-resistant prostate cancer: a Latin America perspective
por: Sade, Juan Pablo, et al.
Publicado: (2018)

Saudi oncology society and Saudi urology association combined clinical management guidelines for renal cell carcinoma
por: Bazarbashi, Shouki, et al.
Publicado: (2014)

Saudi Oncology Society clinical management guidelines for renal cell carcinoma
por: Bazarbashi, Shouki, et al.
Publicado: (2011)

Challenges in the implementation of ultrasensitive liquid biopsy approaches in precision oncology
por: Desai, Aakash, et al.
Publicado: (2023)

Saudi oncology society and Saudi urology association combined clinical management guidelines for testicular germ cell tumors
por: Alotaibi, Mohammed, et al.
Publicado: (2014)

Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for renal cell carcinoma
por: Alghamdi, Abdullah, et al.
Publicado: (2016)

Saudi Oncology Society clinical management guidelines for prostate cancer
por: Abusamra, Ashraf J, et al.
Publicado: (2011)

Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer
por: Alkhateeb, Sultan, et al.
Publicado: (2014)

CATCH: A Prospective Precision Oncology Trial in Metastatic Breast Cancer
por: Hlevnjak, Mario, et al.
Publicado: (2021)

Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for testicular germ cell tumors
por: Alotaibi, Mohammed, et al.
Publicado: (2016)

Saudi Oncology Society clinical management guidelines for urinary bladder cancer
por: Al Othman, Khaled, et al.
Publicado: (2011)

Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer
por: Abusamra, Ashraf, et al.
Publicado: (2016)

Utilization and Outcomes of Surgical Castration in Comparison to Medical Castration in Metastatic Prostate Cancer
por: Garje, Rohan, et al.
Publicado: (2019)

Implementing the FAIR Data Principles in precision oncology: review of supporting initiatives
por: Vesteghem, Charles, et al.
Publicado: (2019)

Saudi Oncology Society clinical management guidelines for testicular germ cell tumors
por: Al Otaibi, Mohammed, et al.
Publicado: (2011)

Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for urothelial cell carcinoma of the urinary bladder
por: Alkhateeb, Sultan, et al.
Publicado: (2016)

Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for renal cell carcinoma 2017
por: Alsharm, Abdullah, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hl8ck1a4s1ifqqlafm7oafk6s2